Clinical Trial Update: A Clinical Trial of Decitabine in Patients With Myelodysplastic Syndrome [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of decitabine in patients with myelodysplastic syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• Dacogen (decitabine)

Snippet

Sponsor: Eisai Inc. | Conditions: Myelodysplastic Syndrome | Phase 1 | Status: TERMINATED